North America Brain Cancer Diagnostics Market
Historic Data:    |   Base Year: 2023   |   Forecast Period: 2024-2031
Forecast to 2028 - COVID-19 Impact and Regional Analysis By Diagnostic Type (Imaging Test, Lumbar Puncture, Biopsy, Molecular Testing, and Others); Cancer Type (Acoustic Neuroma, Astrocytoma, Craniopharyngiomas, Ganglioneuromas, Glioblastoma Multiforme, Meningiomas, Ependymomas, and Others); End User (Hospitals, Specialty Clinics, Ambulatory Surgical Centers, and Others)

No. of Pages: 151    |    Report Code: TIPRE00025904    |    Category: Life Sciences

Available Report Formats

pdf-format excel-format pptx-format
Request Free Sample Buy Now
North America Brain Cancer Diagnostics Market
Free Sample Buy Now

1. Introduction

1.1 Business Market Insights Research Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights
2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research
3.2 Primary Research
  • 3.2.1 Hypothesis formulation:
  • 3.2.2 Macro-economic factor analysis:
  • 3.2.3 Developing base number:
  • 3.2.4 Data Triangulation:
  • 3.2.5 Country level data:

4. North America Brain Cancer Diagnostics Market Landscape

4.1 Market Overview
4.2 Porter's Five Forces Analysis
  • 4.2.1 Bargaining Power of Suppliers
  • 4.2.2 Bargaining Power of Buyers
  • 4.2.3 Threat of New Entrants
  • 4.2.4 Competitive Rivalry
  • 4.2.5 Threat of Substitutes
4.3 Ecosystem Analysis
  • 4.3.1 Raw Material Suppliers
  • 4.3.2 Manufacturers
  • 4.3.3 Distributors/Suppliers
  • 4.3.4 End Users

5. North America Brain Cancer Diagnostics Market – Key Market Dynamics

5.1 Growth Drivers
  • 5.1.1
  • 5.1.2 Rising incidence of brain tumors.
  • 5.1.3 Advancements in diagnostic imaging technologies.
  • 5.1.4 Growing awareness of early detection benefits.
5.2 Market Opportunities
  • 5.2.1
  • 5.2.2 Development of liquid biopsy tests.
  • 5.2.3 Collaborations with research institutions.
  • 5.2.4 Expansion of diagnostic services in hospitals
5.3 Future Trends
  • 5.3.1
  • 5.3.2 Increased use of AI in diagnostics.
  • 5.3.3 Growth in precision medicine approaches.
  • 5.3.4 Focus on non-invasive diagnostic methods.
5.4 Impact of Drivers and Restraints

6. North America Brain Cancer Diagnostics Market Regional Analysis

6.1 North America Brain Cancer Diagnostics Market Overview
6.2 North America Brain Cancer Diagnostics Market Revenue 2019-2028 (US$ Million)
6.3 North America Brain Cancer Diagnostics Market Forecast Analysis

7. North America Brain Cancer Diagnostics Market Analysis – by Diagnostic Type

7.1 Imaging Test
  • 7.1.1 Overview
  • 7.1.2 Imaging Test: North America Brain Cancer Diagnostics Market – Revenue and Forecast to 2031 (US$ Million)
7.2 Lumbar Puncture
  • 7.2.1 Overview
  • 7.2.2 Lumbar Puncture: North America Brain Cancer Diagnostics Market – Revenue and Forecast to 2031 (US$ Million)
7.3 Biopsy
  • 7.3.1 Overview
  • 7.3.2 Biopsy: North America Brain Cancer Diagnostics Market – Revenue and Forecast to 2031 (US$ Million)
7.4 Molecular Testing
  • 7.4.1 Overview
  • 7.4.2 Molecular Testing: North America Brain Cancer Diagnostics Market – Revenue and Forecast to 2031 (US$ Million)

8. North America Brain Cancer Diagnostics Market Analysis – by Cancer Type

8.1 Acoustic Neuroma
  • 8.1.1 Overview
  • 8.1.2 Acoustic Neuroma: North America Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
8.2 Astrocytoma
  • 8.2.1 Overview
  • 8.2.2 Astrocytoma: North America Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
8.3 Craniopharyngiomas
  • 8.3.1 Overview
  • 8.3.2 Craniopharyngiomas: North America Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
8.4 Ganglioneuromas
  • 8.4.1 Overview
  • 8.4.2 Ganglioneuromas: North America Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
8.5 Glioblastoma Multiforme
  • 8.5.1 Overview
  • 8.5.2 Glioblastoma Multiforme: North America Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
8.6 Meningiomas
  • 8.6.1 Overview
  • 8.6.2 Meningiomas: North America Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
8.7 Ependymomas
  • 8.7.1 Overview
  • 8.7.2 Ependymomas: North America Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

9. North America Brain Cancer Diagnostics Market Analysis – by End User

9.1 Hospitals
  • 9.1.1 Overview
  • 9.1.2 Ependymomas: North America Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
9.2 Specialty Clinics
  • 9.2.1 Overview
  • 9.2.2 Ependymomas: North America Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
9.3 Ambulatory Surgical Centers
  • 9.3.1 Overview
  • 9.3.2 Ependymomas: North America Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

10. North America Brain Cancer Diagnostics Market – North America Analysis

10.1 North America
  • 10.1.1 North America Brain Cancer Diagnostics Market Breakdown, by Key Country, 2022 and 2028 (%)
  • 10.1.1.1 North America Brain Cancer Diagnostics Market – Revenue and Forecast Analysis – by Country
  • 10.1.1.1 US: North America Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
    • 10.1.1.1.1 US: North America Brain Cancer Diagnostics Market Breakdown, by Diagnostic Type
    • 10.1.1.1.2 US: North America Brain Cancer Diagnostics Market Breakdown, by Cancer Type
    • 10.1.1.1.3 US: North America Brain Cancer Diagnostics Market Breakdown, by End User
  • 10.1.1.2 Canada: North America Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
    • 10.1.1.2.1 Canada: North America Brain Cancer Diagnostics Market Breakdown, by Diagnostic Type
    • 10.1.1.2.2 Canada: North America Brain Cancer Diagnostics Market Breakdown, by Cancer Type
    • 10.1.1.2.3 Canada: North America Brain Cancer Diagnostics Market Breakdown, by End User
  • 10.1.1.3 Mexico : North America Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
    • 10.1.1.3.1 Mexico : North America Brain Cancer Diagnostics Market Breakdown, by Diagnostic Type
    • 10.1.1.3.2 Mexico : North America Brain Cancer Diagnostics Market Breakdown, by Cancer Type
    • 10.1.1.3.3 Mexico : North America Brain Cancer Diagnostics Market Breakdown, by End User

11. Competitive Landscape

11.1 Heat Map Analysis
11.2 Company Positioning and Concentration

12. North America Brain Cancer Diagnostics Market Industry Landscape

12.1 Overview
12.2 Mergers and Acquisitions
12.3 Agreements, Collaborations, and Joint Ventures
12.4 New Product Launches
12.5 Expansions and Other Strategic Developments

13. Company Profiles

13.1 Thermo Fisher Scientific Inc.
  • 13.1.1 Key Facts
  • 13.1.2 Business Description
  • 13.1.3 Products and Services
  • 13.1.4 Financial Overview
  • 13.1.5 SWOT Analysis
  • 13.1.6 Key Developments
13.2 Siemens Healthineers A
  • 13.2.1 Key Facts
  • 13.2.2 Business Description
  • 13.2.3 Products and Services
  • 13.2.4 Financial Overview
  • 13.2.5 SWOT Analysis
  • 13.2.6 Key Developments
13.3 GE Healthcare
  • 13.3.1 Key Facts
  • 13.3.2 Business Description
  • 13.3.3 Products and Services
  • 13.3.4 Financial Overview
  • 13.3.5 SWOT Analysis
  • 13.3.6 Key Developments
13.4 MDxHealth
  • 13.4.1 Key Facts
  • 13.4.2 Business Description
  • 13.4.3 Products and Services
  • 13.4.4 Financial Overview
  • 13.4.5 SWOT Analysis
  • 13.4.6 Key Developments
13.5 NantOmics
  • 13.5.1 Key Facts
  • 13.5.2 Business Description
  • 13.5.3 Products and Services
  • 13.5.4 Financial Overview
  • 13.5.5 SWOT Analysis
  • 13.5.6 Key Developments
13.6 Biocept, Inc.
  • 13.6.1 Key Facts
  • 13.6.2 Business Description
  • 13.6.3 Products and Services
  • 13.6.4 Financial Overview
  • 13.6.5 SWOT Analysis
  • 13.6.6 Key Developments
13.7 Koninklijke Philips N.V
  • 13.7.1 Key Facts
  • 13.7.2 Business Description
  • 13.7.3 Products and Services
  • 13.7.4 Financial Overview
  • 13.7.5 SWOT Analysis
  • 13.7.6 Key Developments
13.8 Canon Medical Systems
  • 13.8.1 Key Facts
  • 13.8.2 Business Description
  • 13.8.3 Products and Services
  • 13.8.4 Financial Overview
  • 13.8.5 SWOT Analysis
  • 13.8.6 Key Developments
13.9 Hitachi, Ltd.
  • 13.9.1 Key Facts
  • 13.9.2 Business Description
  • 13.9.3 Products and Services
  • 13.9.4 Financial Overview
  • 13.9.5 SWOT Analysis
  • 13.9.6 Key Developments
13.10 Neusoft Medical Systems
  • 13.10.1 Key Facts
  • 13.10.2 Business Description
  • 13.10.3 Products and Services
  • 13.10.4 Financial Overview
  • 13.10.5 SWOT Analysis
  • 13.10.6 Key Developments

14. Appendix

14.1 About Business Market Insights

The List of Companies - N Market

  1. Thermo Fisher Scientific Inc.
  2. Siemens Healthineers A
  3. GE Healthcare
  4. MDxHealth
  5. NantOmics
  6. Biocept, Inc.
  7. Koninklijke Philips N.V
  8. Canon Medical Systems
  9. Hitachi, Ltd.
  10. Neusoft Medical Systems
north-america-brain-cancer-diagnostics-market